Skip to main content
editorial
. 2022 Jan 17;29(2):263–265. doi: 10.1038/s41418-021-00909-6

Fig. 1. Viral and cellular targets of SARS-CoV-2.

Fig. 1

The intracellular replication of SARS-CoV-2 is mediated by the viral RNA-dependent RNA polymerase (NSP12). The incorporation of remdesivir terminates the assemble of viral genomes. However, the efficacy of remdesivir could be compromised by RNA proofreading complex (NSP10/NSP14), Blocking NSP14 activity by solfacone dramatically lowered the IC50 of remdesivir. The continuous intracellular virus replication would induce typical cellular senescence with the induction of anti-apoptotic Bcl-2 family and PI3K signaling cascade. Senolytics, such as fisetin and quercetin, could help to clear infected cells and resolve inflammation in COVID-19 infections.